Joel David Mayersohn - 12 Dec 2024 Form 4 Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Role
Director
Signature
/s/ Lorna A. Knick, by Power of Attorney
Issuer symbol
CTOR
Transactions as of
12 Dec 2024
Transactions value $
$0
Form type
4
Filing time
16 Dec 2024, 17:05:14 UTC
Previous filing
13 Oct 2022
Next filing
07 Aug 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTOR Stock Option (Right to Buy) Award $0 +250K $0.00 250K 12 Dec 2024 Common Stock 250K $1.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date